It was demonstrated that transfection with these miRNAs induces a 30% down-regulation of wild-type MYB mRNA level in a T-cell acute lymphoblastic leukemia cell line, whereas this treatment does not decrease levels of the chimeric transcripts in ACC cells [4]. This evidence concerns the gene MYB and adrenal cortex carcinoma.